Literature DB >> 14619834

[Therapy of cryptorchidism. Viewpoints for optimizing fertility].

B O Backhaus1, S C Müller.   

Abstract

The pathophysiology of cryptorchidism--the most common anomaly of the urogenital tract--is still not well understood. Delayed treatment results in reduced fertility and even after correct therapy the risk of malignancy after puberty remains elevated. Intra-uterine maternal hCG stimulation and a postpartal GnRH rise in conjunction with a nor-mal hypothalamus-pituitary-gonadal-axis are essential for the normal development of the germ cells. Disturbances in these key-events of hormonal stimulation lead to a pre-pubertal hypogonadotropic hypogonadism with impaired fertility. Only the early beginning of hormonal therapy, best done sequentially (GnRH + hCG), can promote the physiologic descend and normal fertility. Surgery, even if performed early enough, has little impact on the physiology of germ cell development, cannot alter the risk of subsequent malignancy and improves only the cosmetic appearance. To reach optimal fertility each not descended testicle should be treated primarily using hormonal therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619834     DOI: 10.1007/s00120-003-0432-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  12 in total

1.  Plasma testosterone in preterm infants with cryptorchidism.

Authors:  B A Baker; R Morley; A Lucas
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

2.  Iatrogenic cryptorchidism resulting from hernia repair.

Authors:  G W Kaplan
Journal:  Surg Gynecol Obstet       Date:  1976-05

3.  An epidemiological study on undescended testis.

Authors:  A Czeizel; E Erödi; J Tóth
Journal:  J Urol       Date:  1981-10       Impact factor: 7.450

4.  Cryptorchidism, and epidemiologic study with emphasis on the relationship to central nervous system dysfunction.

Authors:  R H Depue
Journal:  Teratology       Date:  1988-04

5.  Seasonal variations in cryptorchidism.

Authors:  M B Jackson; A J Swerdlow
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

6.  Effect of synthetic luteinizing hormone-releasing hormone on the release of gonadotropins in hypophysogonadal disorders of children and adolescents. IV. Undescended testes.

Authors:  J C Job; P E Garnier; J L Chaussain; J E Toublanc; P Canlorbe
Journal:  J Pediatr       Date:  1974-03       Impact factor: 4.406

7.  Treatment of cryptorchidism with low doses of buserelin over a 6-months period.

Authors:  F Hadziselimovic; D Huff; J Duckett; B Herzog; J Elder; H Snyder; M Buser
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

Review 8.  Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy.

Authors:  C Chilvers; N E Dudley; M H Gough; M B Jackson; M C Pike
Journal:  J Pediatr Surg       Date:  1986-08       Impact factor: 2.545

9.  Association between abdominal wall defects and cryptorchidism.

Authors:  L M Kaplan; M A Koyle; G W Kaplan; J H Farrer; J Rajfer
Journal:  J Urol       Date:  1986-09       Impact factor: 7.450

10.  Combined therapy with LHRH and HCG in cryptorchid infants.

Authors:  R Lala; P Matarazzo; P Chiabotto; C de Sanctis; F Canavese; F Hadziselimovic
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.